Search clinical trials for: flortaucipir F18

Total 1467 results

Avid Radiopharmaceuticals

Completed

Augmenting Flortaucipir Dosimetry Estimates

Alzheimer's Disease

United States
Eli Lilly and Company

Not yet recruiting

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Alzheimer Disease

United States, United Kingdom, Japan
Avid Radiopharmaceuticals

Completed

Tau Screening Study in Subjects With Early Symptomatic AD

Alzheimer Disease

United States
Avid Radiopharmaceuticals

Completed

Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease

Alzheimer Disease

United States
Avid Radiopharmaceuticals

Completed

18F-AV-1451 Autopsy Study

Alzheimer's Disease

United States, Australia
Avid Radiopharmaceuticals

Completed

Tau Screening Study in Patients With Early Symptomatic AD

Alzheimer Disease

United States, Canada
Avid Radiopharmaceuticals

Completed

Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease

Alzheimer Disease | Mild Cognitive Impairment
Avid Radiopharmaceuticals

Terminated

Flortaucipir 18F PET Imaging in BIOCARD Study

Cognitive Decline

United States
Avid Radiopharmaceuticals
The Cleveland Clinic

Completed

Tau Imaging in Professional Fighters

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

Flortaucipir PET Imaging in Subjects With FTD

Frontotemporal Dementia

United States
Avid Radiopharmaceuticals

Completed

Clinical Evaluation of Flortaucipir F 18

Depression | Traumatic Brain Injury | Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy

United States
Avid Radiopharmaceuticals

Completed

Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects (MCI)

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers

Corticobasal Degeneration | Progressive Supranuclear Palsy

United States
University of North Carolina, Chapel Hill
Boston Children's Hospital; Medical College of Wisconsin; National Football League

Enrolling by invitation

NFL LONG Prospective Study

Concussion, Brain

United States
Avid Radiopharmaceuticals

Terminated

Imaging Characteristics of a Follow-up 18F-AV-1451 Scan

Alzheimer's Disease

United States
Neil M Rofsky, MD, MHA

Completed

Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study

Alzheimer Disease | Cognitive Decline

United States
Avid Radiopharmaceuticals

Completed

Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects

Alzheimer Disease

United States
Eli Lilly and Company

Completed

A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Alzheimer Disease

United States, Japan, United Kingdom
Tammie L. S. Benzinger, MD, PhD

Withdrawn

Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers. (Protocol_Z)

Alzheimer Disease

United States
Avid Radiopharmaceuticals

Completed

A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation

Alzheimer Disease

United States
Siemens Molecular Imaging

Terminated

Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects

Breast Cancer

United States
Indiana University
National Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Alzheimer's Association

Recruiting

Longitudinal Early-onset Alzheimer's Disease Study Protocol (LEADS)

Alzheimer Disease | Mild Cognitive Impairment | Early Onset Alzheimer Disease

United States
University of Southern California
National Institute on Aging (NIA); Northern California Institute of Research... and other collaborators

Completed

Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)

Mild Cognitive Impairment (MCI) | Alzheimer's Disease (AD) | Significant Memory Concern (SMC) | Early Mild Cognitive Impairment (EMCI) | Late Mild Cognitive Impairment (LMCI)

United States, Canada
Avid Radiopharmaceuticals

Terminated

A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 (T808)

Alzheimers Disease

United States
Mayo Clinic
National Institute on Aging (NIA)

Active, not recruiting

Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

Alzheimer Disease

United States
Avid Radiopharmaceuticals

Terminated

A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807

Alzheimers Disease | AD

United States
Sid E. O'Bryant

Completed

Health & Aging Brain Study: Health Disparities TAU Project

Brain Aging in Mexican Americans

United States
Ganesh Babulal

Recruiting

Depression and Driving (D&D)

Depression | Drive

United States
Tammie L. S. Benzinger, MD, PhD

Recruiting

Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND) (HASD_PIB_IND)

Alzheimer Disease

United States
Tammie L. S. Benzinger, MD, PhD

Completed

Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans (ADRCproj1)

Alzheimer Disease

United States
University of Southern California
National Institute on Aging (NIA); Northern California Institute of Research... and other collaborators

Recruiting

Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4)

Dementia | Alzheimer Disease | Mild Cognitive Impairment

United States, Canada
Johns Hopkins University
National Institute on Aging (NIA)

Withdrawn

Tau Tracer Comparison in Healthy Controls and Alzheimer's Disease Patients

Healthy | Alzheimer Disease

United States
Mayo Clinic

Withdrawn

Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography (PEM-FES)

Breast Neoplasm

United States
Assistance Publique Hopitaux De Marseille

Unknown

Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45).

Alzheimer's Disease

France
The Hospital for Sick Children

Completed

18FDG-PET Imaging to Detect Changes in Airways Inflammation in Cystic Fibrosis Patients

Cystic Fibrosis

Canada
Washington University School of Medicine

Terminated

Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery

Rectal Neoplasms

United States
University Health Network, Toronto

Recruiting

Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study

Head and Neck Squamous Cell Carcinoma

Canada
University Hospital, Caen

Unknown

Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH) (TEP-GVH)

Chronic Graft Versus Host Disease

France
National Institute of Neurological Disorders and...

Completed

Metabolic Abnormalities in Children With Epilepsy

Seizures | Generalized Epilepsy | Metabolic Disease | Infantile Spasms | Partial Epilepsy

United States
University of Saskatchewan
Saskatoon Health Region; Sylvia Fedoruk Canadian Centre for Nuclear Innovation

Completed

Registry Type Study to Monitor for Adverse Drug Reactions to Fedoruk Manufactured [F-18]-Fludeoxyglucose

Positron-Emission Tomography and Cone-Beam Computed Tomography
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Completed

Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults

Dengue

United States
Institut de cancérologie Strasbourg Europe

Recruiting

Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC) (ATICC)

Cervical Cancer

France
Centre Hospitalier Universitaire de Nīmes

Completed

Metabolic Anomolies Associated With the 6 Month Clinical Evolution of Patients Suffering From Motor Conversion Disorder (HYCORE)

Conversion Disorder

France
Abramson Cancer Center of the University of Pennsylvania
National Cancer Institute (NCI)

Terminated

Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer

Cervical Cancer

United States
Zhejiang University

Completed

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma | Diagnosis | Staging | 18F-FDG | 18F-FAPI

China
American College of Radiology Imaging Network
National Cancer Institute (NCI)

Terminated

FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy (ACRIN6678)

Lung Cancer

United States
Kejal Kantarci
National Institute of Neurological Disorders and Stroke (NINDS)

Enrolling by invitation

Longitudinal Imaging Biomarkers of Disease Progression in DLB

Lewy Body Disease

United States

Search clinical trials for: flortaucipir F18

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations